KINERET
Google image searchProduct monograph
Active ingredient
anakinra, 150 MG/ML
DIN: 02245913
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: 100MG PER SYRINGE SINGLE-USE, PRESERVATIVE-FREE PREFILLED SYRINGES
Schedule: Prescription / Schedule D
Company: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Date: 22-JUN-2011
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AC — Interleukin inhibitors (ATC, ATC/DDD)
- L04AC03 — ANAKINRA (ATC/DDD)
Reference brand drug: Kineret
Pharmaceutical standard: MFR
